Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soichiro Shibui

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Oncology|December 10, 2013
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expressionMasashi Okada, Atsushi Sato, Keita Shibuya, et al.
Brain Pathology (Zurich, Switzerland)|July 22, 2014
Revisiting TP53 Mutations and Immunohistochemistry--A Comparative Study in 157 Diffuse GliomasHirokazu Takami, Akihiko Yoshida, Shintaro Fukushima, et al.
Japanese Journal of Clinical Oncology|November 26, 2015
Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcomeMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Stem Cells (Dayton, Ohio)|September 22, 2010
Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cellsJun Sunayama, Ken-Ichiro Matsuda, Atsushi Sato, et al.
Scientific Reports|July 21, 2012
Targeting JNK for therapeutic depletion of stem-like glioblastoma cellsKen-ichiro Matsuda, Atsushi Sato, Masashi Okada, et al.
Neuro-Oncology|September 24, 2010
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cellsJun Sunayama, Atsushi Sato, Ken-ichiro Matsuda, et al.
Journal of Neuro-Oncology|July 24, 2008
Immunohistochemical profiles of brain metastases from breast cancerKan Yonemori, Koji Tsuta, Chikako Shimizu, et al.
Acta Neuropathologica|June 15, 2013
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q lossHideyuki Arita, Yoshitaka Narita, Shintaro Fukushima, et al.
Neuro-Oncology|November 29, 2013
H3F3A K27M mutations in thalamic gliomas from young adult patientsKoki Aihara, Akitake Mukasa, Kengo Gotoh, et al.
Neurologia Medico-Chirurgica|June 16, 2016
Working Conditions and Lifestyle of Female Surgeons Affiliated to the Japan Neurosurgical Society: Findings of Individual and Institutional SurveysTakamitsu Fujimaki, Soichiro Shibui, Yoko Kato, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Oncology|December 10, 2013
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expressionMasashi Okada, Atsushi Sato, Keita Shibuya, et al.
Brain Pathology (Zurich, Switzerland)|July 22, 2014
Revisiting TP53 Mutations and Immunohistochemistry--A Comparative Study in 157 Diffuse GliomasHirokazu Takami, Akihiko Yoshida, Shintaro Fukushima, et al.
Japanese Journal of Clinical Oncology|November 26, 2015
Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcomeMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Stem Cells (Dayton, Ohio)|September 22, 2010
Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cellsJun Sunayama, Ken-Ichiro Matsuda, Atsushi Sato, et al.
Scientific Reports|July 21, 2012
Targeting JNK for therapeutic depletion of stem-like glioblastoma cellsKen-ichiro Matsuda, Atsushi Sato, Masashi Okada, et al.
Neuro-Oncology|September 24, 2010
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cellsJun Sunayama, Atsushi Sato, Ken-ichiro Matsuda, et al.
Journal of Neuro-Oncology|July 24, 2008
Immunohistochemical profiles of brain metastases from breast cancerKan Yonemori, Koji Tsuta, Chikako Shimizu, et al.
Acta Neuropathologica|June 15, 2013
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q lossHideyuki Arita, Yoshitaka Narita, Shintaro Fukushima, et al.
Neuro-Oncology|November 29, 2013
H3F3A K27M mutations in thalamic gliomas from young adult patientsKoki Aihara, Akitake Mukasa, Kengo Gotoh, et al.
Neurologia Medico-Chirurgica|June 16, 2016
Working Conditions and Lifestyle of Female Surgeons Affiliated to the Japan Neurosurgical Society: Findings of Individual and Institutional SurveysTakamitsu Fujimaki, Soichiro Shibui, Yoko Kato, et al.
Pageof 10